Cholinesterase inhibitors for delirium

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Overshott, Ross ^a   Karim, S ^b   Burns, A ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE; RIVASTIGMINE; TACRINE;

CHOLINERGIC SYSTEM; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFUSION; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MORTALITY; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 44949179484     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005317.pub2     Document Type: Review

References (41)

1. Liptzin 2005 {published data only} Liptzin B, Laki A, Garb JL, Fingeroth R, Kushell R. Donepezil in the prevention and treatment of post-surgical delirium. American Journal of Geriatric Psychiatry 2005;13(12):1100-6.
2. Hori 2003 Hori K, Tominaga I, Inada T, Oda T, Hirai S, Hori I, Onaya M, Teramoto H. Donepezil-responsive alcohol-related prolonged delirium. Psychiatry and Clinical Neurosciences 2003;57:603-4.
3. Kalisvaart 2004 Kalisvaart CJ, Boelaarts L, De Jonghe JFM, Kat MG. Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase ihibitor rivastigmine. Ned Tijdschr Geneeskd 2004;148(30):1501-4.
4. Kobayashi 2004 Kobayashi K, Higashima M, Mutou K, Kidani T, Tachibana O, Yamashita J, Koshino Y. Severe delirium due to basal forebrain vascular lesion and efficacy of donepezil. Progess in Neuro- Psychopharmacology and Biological Psychiatry 2004;28:1189-94.
5. Moretti 2004 Moretti R, Torre P, Antonello R, Cattaruzza T, Cazzato G. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients. American Journal of Alzheimer's Disease and Other Dementias 2004;19(6):333-9.
6. Noyan 2003 Noyan MA, Elbi H, Aksu H. Donepezil for anticholinergic drug intoxication. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003;27:885-7.
7. Slatkin 2004 Slatkin N, Rhiner M. Treatment of opiod-induced delirium with acetylcholinesterase Inhibitors. Journal of Pain and Symptom Management 2004;27(3):268-73.
8. APA 1994 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
9. Birks 2003 Birks J, Harvey R. Donepezil for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art.No.: CD001190. DOI: 10.1002/14651858.CD001190.pub2.Art. No.: CD001190. DOI:10.1002/14651858.CD001190.pub2.
10. Birks 2004 Birks J, Grimley Evans J, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD001191. DOI: 10.1002/14651858.CD001191. Art. No.: CD001191. DOI: 10.1002/14651858.CD001191.
11. Bross 1994 Bross MH, Tatum NO. Delirium in the elderly patient. American Family Physician 1994;50(6):1325-32.
12. Bucht 1999 Bucht G, Gustafson Y, Sandberg O. Epidemiology of Delirium. Dementia and Geriatric Cognitive Disorders 1999;10:315- 18.
13. CAM 1990 Inouye SK, van Dyck CH, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the Confusion Assessment Method. Annals of Internal Medicine 1990;113:941-8.
14. Cole 1993 Cole M, Primeau F. Prognosis of delirium in elderly hospital patients. CMAJ 1993;149:41-6.
15. DRS 1988 Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Research 1988;23:89-97.
16. DSI 1992 Albert MS, Levkoff SE, Reilly C, et al.The Delirium Symptom Interview: an interview for the detection of delirium symptoms in hospitalized patients. Journal of Geriatric Psychiatry and Neurology 1992;5:14-21.
17. Fann 2000 Fann JR. The epidemiology of delirium: a review of studies and methodological issues. Seminars in Clinical Neuropsychiatry 2000;5:64-76.
18. Fischer 2001 Fischer P. Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor. Journal of Clinical Psychopharmacology 2001;21(1):118.
19. Flacker 1998 Flacker JM, Marcantonio ER. Delirium in the elderly. Optimal management. Drugs Aging 1998;13(2):119-30.
20. Folstein 1975 Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12:189-98.
21. Gustafson 1988 Gustafson Y, Berggren D, Brinnstrom B. Acute confusional states in elderly patients treated for femoral neck fracture. Journal of American Geriatrics Society 1988;36:525-30.
22. Inouye 1994 Inouye SK. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalised patients. American Journal of Medicine 1994;97:278- 88.
23. Inouye 1998 Inouye S, Rushing J, Foreman M, Palmer R, Pompei P. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. Journal of General Internal Medicine 1998;13:234-42.
24. Itil 1966 Itil T, Fink M. Anticholinergic-induced delirium: experimental modification, quantitative EEG and behavioural correlations. Journal of Nervous and Mental Disorders 1966;143:492-507.
25. Koponen 1999 Koponen HJ. Neurochemistry and delirium. Dementia and Geriatric Cognitive Disorders 1999;10(5):339-41.
26. Lipowski 1987 Lipowski ZJ. Delirium (acute confusional states). JAMA 1987;258:1789-92.
27. Lipowski 1990 Lipowski ZJ. Delirium: acute confusional states. New York: Oxford University Press, 1990.
28. Loy 2004 Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD001747. DOI: 10.1002/14651858.CD001747.pub3.Art. No.: CD001747. DOI: 10.1002/14651858.CD001747.pub3.
29. McCusker 2002 McCusker J, Cole M, Abrahamowicz M, Primeau F, Belzile E. Deliriumpredicts 12-month mortality. Archives of Internal Medicine 2002;162:457-63.
30. Mintzer 2000 Mintzer J, Burns A. Anticholinesterase side effects of drugs in elderly people. Journal of the Royal Society of Medicine 2000;93:457-62.
31. Pompei 1994 Pompei P, Foreman M, Rudberg MA, Inouye SK, Braund V, Cassel CK. Deliriumin hospitalised older persons: outcomes and predictors. Journal of the American Geriatrics Society 1994;42:809-15.
32. Qizilbash 1998 Qizilbash N, Whitehead A, Higgins J, Wilcock G, Schneider L, Farlow M for the Dementia Trialists' Collaboration. Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. JAMA 1998;280:1777-82.
33. Rabins 1982 Rabins PV, Folstein MF. Delirium and dementia: diagnostic criteria and fatality rates. British Journal of Psychiatry 1982;140:149-53.
34. Sandberg 1998 Sandberg O, Gustafson Y, Brannstrom B, Bucht G. Prevalence of dementia, delirium and psychiatric symptoms in various care settings for the elderly. Scandinavian Journal Society of Medicine 1998;26(1):56-62.
35. Someya 2001 Someya T, Taro E, Hara T, Yagi G, Suzuki J. A survey on the drug therapy for delirium. Psychiatry and Clinical Neurosciences 2001;55(4):397-401.
36. Sunderland 1989 Sunderland T, Hill JL, Mellow AM, et al.Clock-drawing in Alzheimer's disease: a novel measure of dementia severity. Journal of the American Geriatrics Society 1989;37:725-9.
37. Trzepacz 1996 Trzepacz PT. Delirium, advances in diagnosis, pathophysiology and treatment. Psychiatry Clinics North America 1996;19:335-46.
38. Trzepacz 1999 Trzepacz PT. Update on the neuropathogenesis of delirium. Dementia and Geriatric Cognitive Disorders 1999;10:330- 4.
39. Tune 1993 Tune L, Carr S, Cooper T, Klug B, Golinger RC. Association of anticholinergic activity of prescribed medications with postoperative delirium. The Journal of Neuropsychiatry and Clinical Neurosciences 1993;5(2):208-10.
40. Wengel 1998 Wengel SP, Roccaforte WH, Burke WJ. Donepezil improves symptoms of delirium in dementia: implications for future research. Journal of Geriatric Psychiatry and Neurology 1998;11:59-61.
41. WHO 1992 World Health Organisation. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: WHO, 1992.